Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasma cell | 10 studies | 36% ± 16% | |
| plasmacytoid dendritic cell | 5 studies | 19% ± 3% | |
| epithelial cell | 4 studies | 27% ± 5% | |
| classical monocyte | 3 studies | 19% ± 2% | |
| non-classical monocyte | 3 studies | 25% ± 6% | |
| IgG plasma cell | 3 studies | 21% ± 4% | |
| ciliated cell | 3 studies | 23% ± 3% | |
| macrophage | 3 studies | 23% ± 3% | |
| dendritic cell | 3 studies | 22% ± 2% | |
| plasmablast | 3 studies | 34% ± 17% |
Insufficient scRNA-seq data for expression of ARSA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2490.18 | 1445 / 1445 | 100% | 28.14 | 183 / 183 |
| pancreas | 100% | 2623.87 | 328 / 328 | 100% | 42.96 | 178 / 178 |
| thymus | 100% | 4221.35 | 653 / 653 | 100% | 50.05 | 604 / 605 |
| liver | 100% | 2318.35 | 226 / 226 | 100% | 44.71 | 405 / 406 |
| skin | 100% | 2143.36 | 1808 / 1809 | 100% | 54.87 | 471 / 472 |
| kidney | 100% | 3098.33 | 89 / 89 | 100% | 35.79 | 897 / 901 |
| prostate | 100% | 3755.91 | 245 / 245 | 99% | 58.66 | 499 / 502 |
| lung | 100% | 3506.38 | 578 / 578 | 99% | 41.33 | 1142 / 1155 |
| uterus | 100% | 2825.73 | 170 / 170 | 99% | 37.02 | 453 / 459 |
| intestine | 100% | 3212.67 | 966 / 966 | 99% | 32.11 | 520 / 527 |
| stomach | 100% | 2571.22 | 359 / 359 | 99% | 29.63 | 282 / 286 |
| breast | 100% | 3450.36 | 459 / 459 | 98% | 39.85 | 1099 / 1118 |
| bladder | 100% | 2866.90 | 21 / 21 | 98% | 37.42 | 494 / 504 |
| brain | 99% | 1885.75 | 2615 / 2642 | 98% | 27.79 | 692 / 705 |
| adrenal gland | 100% | 2754.00 | 258 / 258 | 97% | 25.59 | 223 / 230 |
| ovary | 99% | 1342.68 | 178 / 180 | 94% | 21.09 | 403 / 430 |
| adipose | 100% | 2941.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 43.10 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 43.94 | 29 / 29 |
| spleen | 100% | 5261.93 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 38.13 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.82 | 1 / 1 |
| blood vessel | 100% | 2625.64 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 2124.64 | 858 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 3189.61 | 918 / 929 | 0% | 0 | 0 / 0 |
| muscle | 76% | 638.91 | 614 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006629 | Biological process | lipid metabolic process |
| GO_0035578 | Cellular component | azurophil granule lumen |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0005764 | Cellular component | lysosome |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0004098 | Molecular function | cerebroside-sulfatase activity |
| GO_0008484 | Molecular function | sulfuric ester hydrolase activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0004065 | Molecular function | arylsulfatase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ARSA |
| Protein name | Arylsulfatase A isoform 1 Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase) [Cleaved into: Arylsulfatase A component B; Arylsulfatase A component C] Arylsulfatase A Arylsulfatase A isoform 2 |
| Synonyms | |
| Description | FUNCTION: Hydrolyzes cerebroside sulfate. . |
| Accessions | ENST00000395619.3 ENST00000608497.1 A0A0C4DFZ2 A0A0S2Z309 V9GYR0 ENST00000356098.9 P15289 ENST00000216124.10 A0A0S2Z373 ENST00000453344.6 [P15289-2] ENST00000395621.7 |
